• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

接受富马酸二甲酯治疗的脱髓鞘疾病患者中的非典型播散性带状疱疹感染。

Atypical disseminated herpes zoster infections in patients with demyelinating disease treated with dimethyl fumarate.

作者信息

Balshi Alexandra, Dempsey John, Sloane Jacob A

机构信息

Department of Neurology, Beth Israel Deaconess Medical Center, Harvard Medical School, 330 Brookline Ave., Kirstein 215, Boston, MA, 02215, USA.

出版信息

J Neurovirol. 2024 Dec;30(5-6):556-558. doi: 10.1007/s13365-024-01230-x. Epub 2024 Oct 21.

DOI:10.1007/s13365-024-01230-x
PMID:39433711
Abstract

We report two patients who developed atypical, disseminated herpes zoster infections while on dimethyl fumarate (DMF) treatment, one with varicella zoster virus (VZV) encephalitis and another with herpes zoster oticus resulting in lasting motor and sensory deficits. We recommend vaccination against VZV prior to DMF initiation be incorporated as standard of care, as ensuring patients are protected against VZV before starting DMF can prevent such severe outcomes.

摘要

我们报告了两名在接受富马酸二甲酯(DMF)治疗期间发生非典型播散性带状疱疹感染的患者,其中一名患有水痘带状疱疹病毒(VZV)脑炎,另一名患有耳带状疱疹,导致持续的运动和感觉功能障碍。我们建议在开始使用DMF之前接种VZV疫苗应作为标准治疗措施,因为在开始使用DMF之前确保患者免受VZV感染可以预防此类严重后果。

相似文献

1
Atypical disseminated herpes zoster infections in patients with demyelinating disease treated with dimethyl fumarate.接受富马酸二甲酯治疗的脱髓鞘疾病患者中的非典型播散性带状疱疹感染。
J Neurovirol. 2024 Dec;30(5-6):556-558. doi: 10.1007/s13365-024-01230-x. Epub 2024 Oct 21.
2
Breaking the cycle: considerations for a life-course vaccination strategy against varicella-zoster virus.打破循环:针对水痘-带状疱疹病毒的终生疫苗接种策略考量
Expert Rev Vaccines. 2025 Dec;24(1):556-569. doi: 10.1080/14760584.2025.2514527. Epub 2025 Jun 19.
3
Vaccines for preventing herpes zoster in older adults.用于预防老年人带状疱疹的疫苗。
Cochrane Database Syst Rev. 2023 Oct 2;10(10):CD008858. doi: 10.1002/14651858.CD008858.pub5.
4
Complications of Varicella Zoster Infection of the Central Nervous System.中枢神经系统水痘带状疱疹感染的并发症
Methodist Debakey Cardiovasc J. 2017 Apr-Jun;13(2):76-77. doi: 10.14797/mdcj-13-2-76.
5
Clinical characteristics and treatment of varicella zoster virus central nervous system infection in an Australian tertiary hospital.澳大利亚一家三级医院水痘带状疱疹病毒中枢神经系统感染的临床特征与治疗
Intern Med J. 2025 Jul;55(7):1152-1160. doi: 10.1111/imj.70076. Epub 2025 Apr 21.
6
Atypical varicella zoster virus CNS infections: Diagnostic challenges and the role of multiplex PCR.非典型水痘带状疱疹病毒中枢神经系统感染:诊断挑战与多重聚合酶链反应的作用
Diagn Microbiol Infect Dis. 2025 Oct;113(2):116893. doi: 10.1016/j.diagmicrobio.2025.116893. Epub 2025 May 10.
7
Characteristics of meningitis/encephalitis in adult patients with varicella-zoster virus infection: Experience from tertiary centers in Saga prefecture, Japan.成人水痘-带状疱疹病毒感染患者的脑膜炎/脑炎特征:来自日本佐贺县三级医疗中心的经验
J Neurol Sci. 2025 Aug 15;475:123559. doi: 10.1016/j.jns.2025.123559. Epub 2025 May 26.
8
Incidence, risk factors, and implemented prophylaxis of varicella zoster virus infection, including complicated varicella zoster virus and herpes simplex virus infections, in lenalidomide-treated multiple myeloma patients.来那度胺治疗多发性骨髓瘤患者中水痘带状疱疹病毒感染(包括复杂的水痘带状疱疹病毒和单纯疱疹病毒感染)的发生率、风险因素和预防措施。
Ann Hematol. 2014 Mar;93(3):479-84. doi: 10.1007/s00277-013-1951-6. Epub 2013 Dec 7.
9
Herpes zoster infection in a patient with relapsing-remitting multiple sclerosis treated with diroximel fumarate.使用富马酸二甲酯治疗的复发缓解型多发性硬化症患者发生带状疱疹感染。
BMJ Case Rep. 2025 Apr 2;18(4):e264081. doi: 10.1136/bcr-2024-264081.
10
Immune evasion as a pathogenic mechanism of varicella zoster virus.免疫逃逸作为水痘带状疱疹病毒的一种致病机制。
Semin Immunol. 2001 Feb;13(1):27-39. doi: 10.1006/smim.2001.0293.

引用本文的文献

1
Herpes Zoster Infections With Multiple Sclerosis Disease-Modifying Therapies: A Real-World Pharmacovigilance Study.使用多发性硬化症疾病修正疗法时的带状疱疹感染:一项真实世界药物警戒研究。
Neurol Clin Pract. 2025 Apr;15(2):e200462. doi: 10.1212/CPJ.0000000000200462. Epub 2025 Mar 11.

本文引用的文献

1
High CD4+:CD8+ ratios with herpes zoster infections in patients with multiple sclerosis on dimethyl fumarate.使用富马酸二甲酯治疗的多发性硬化症患者带状疱疹感染时CD4⁺:CD8⁺比值较高。
Mult Scler. 2023 Oct;29(11-12):1465-1470. doi: 10.1177/13524585231189641. Epub 2023 Aug 12.
2
Use of Recombinant Zoster Vaccine in Immunocompromised Adults Aged ≥19 Years: Recommendations of the Advisory Committee on Immunization Practices - United States, 2022.《免疫功能低下的成年(≥19 岁)人群使用重组带状疱疹疫苗:免疫接种实践咨询委员会的建议-美国,2022 年》。
MMWR Morb Mortal Wkly Rep. 2022 Jan 21;71(3):80-84. doi: 10.15585/mmwr.mm7103a2.
3
Long-term safety and efficacy of dimethyl fumarate for up to 13 years in patients with relapsing-remitting multiple sclerosis: Final ENDORSE study results.
长达 13 年的富马酸二甲酯治疗复发缓解型多发性硬化症患者的长期安全性和疗效:最终 ENDORSE 研究结果。
Mult Scler. 2022 Apr;28(5):801-816. doi: 10.1177/13524585211037909. Epub 2021 Sep 1.
4
Aggressive Herpes Zoster in Young Patients With Multiple Sclerosis Under Dimethyl Fumarate: Significance of CD8 and Natural Killer Cells.接受富马酸二甲酯治疗的多发性硬化症年轻患者中的侵袭性带状疱疹:CD8和自然杀伤细胞的意义
Neurol Neuroimmunol Neuroinflamm. 2021 May 28;8(4). doi: 10.1212/NXI.0000000000001017. Print 2021 Jul.
5
Disseminated zoster with paresis in a multiple sclerosis patient treated with dimethyl fumarate.一名接受富马酸二甲酯治疗的多发性硬化症患者出现伴有轻瘫的播散性带状疱疹。
Neurol Neuroimmunol Neuroinflamm. 2016 Mar 9;3(2):e203. doi: 10.1212/NXI.0000000000000203. eCollection 2016 Apr.
6
Reduction of CD8(+) T lymphocytes in multiple sclerosis patients treated with dimethyl fumarate.二甲基富马酸治疗多发性硬化症患者导致 CD8(+)T 淋巴细胞减少。
Neurol Neuroimmunol Neuroinflamm. 2015 Feb 12;2(3):e76. doi: 10.1212/NXI.0000000000000076. eCollection 2015 Jun.
7
Varicella-zoster virus infections in patients treated with fingolimod: risk assessment and consensus recommendations for management.接受芬戈莫德治疗的患者的水痘带状疱疹病毒感染:风险评估和管理共识建议。
JAMA Neurol. 2015 Jan;72(1):31-9. doi: 10.1001/jamaneurol.2014.3065.
8
VZV T cell-mediated immunity.VZV 特异性 T 细胞免疫。
Curr Top Microbiol Immunol. 2010;342:341-57. doi: 10.1007/82_2010_31.